Liu Yinan, Tang Liang, Peng Baifu, Zhao Shaoji, Shao Ziling, Sun Kaiyu, Ye Jinning, Chen Wei, Xu Jianbo
Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, No. 58, Zhongshan 2 Road, Guangzhou, Guangdong, 510080, People's Republic of China; Department of General Surgery, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang, 110000, Liaoning Province, People's Republic of China.
Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, No. 58, Zhongshan 2 Road, Guangzhou, Guangdong, 510080, People's Republic of China.
Redox Biol. 2025 Jul 17;85:103759. doi: 10.1016/j.redox.2025.103759.
Gastric cancer (GC) primarily metastasizes through lymphatic channels, although lymphatic metastasis remains relatively inefficient. Changes in cellular metabolism, known as metabolic reprogramming, plays a significant role in the adaptive survival of cells during the process. Therefore, understanding the mechanism underlying metabolic reprogramming in lymph node (LN) metastasis is crucial for the development of targeted therapies for advanced gastric cancer. This study aimed to investigate the metabolic adaptations of GC cells during LN metastasis, with a particular focus on lipid metabolism reprogramming.
Non-targeted lipidomic sequencing, combined with tumor cell flow sorting and RNA sequencing, was used to explore differences in lipid microenvironments and changes in lipid metabolism pathways between lymph nodes and primary tumors. Single-cell sequencing data were analyzed to confirm these results. Transmission electron microscopy, BODIPY 581/591 staining, and ferroptosis inhibitors were used to confirm the effects of arachidonic acid (AA) on ferroptosis sensitivity in gastric cancer. Public databases and ChIP-qPCR tests were used to investigate the role of PPARγ pathway in regulating FABP1 transcription.
Lipid metabolism pathway was inhibited following lymph node metastasis, with reduced lipid catabolites observed in the lymph nodes. Single-cell data also supported these findings. Physiological concentrations of AA were shown to increase ferroptosis sensitivity, lipid peroxidation, and mitochondrial damage in gastric cancer cells. FABP1 was significantly downregulated in lymph nodes, which mediated the uptake of AA, mitochondrial destruction, and lipid peroxidation. Further analysis revealed that PPARγ, a regulator of FABP1 transcription, was significantly downregulated after lymph node metastasis. Furthermore, our findings revealed that AA reduced the stability of PPARγ protein.
The high concentration of AA in the lymph nodes microenvironment can increase the sensitivity of gastric cancer cells to ferroptosis. Mechanically, AA inhibits the PPARγ pathway to downregulate FABP1 expression, thereby suppressing AA uptake and preventing ferroptosis of gastric cancer cells.
胃癌(GC)主要通过淋巴道转移,尽管淋巴转移效率相对较低。细胞代谢的变化,即代谢重编程,在此过程中对细胞的适应性存活起着重要作用。因此,了解淋巴结(LN)转移中代谢重编程的机制对于晚期胃癌靶向治疗的发展至关重要。本研究旨在探讨GC细胞在LN转移过程中的代谢适应性,特别关注脂质代谢重编程。
采用非靶向脂质组学测序,结合肿瘤细胞流式分选和RNA测序,探索淋巴结与原发肿瘤之间脂质微环境的差异以及脂质代谢途径的变化。分析单细胞测序数据以证实这些结果。使用透射电子显微镜、BODIPY 581/591染色和铁死亡抑制剂来证实花生四烯酸(AA)对胃癌铁死亡敏感性的影响。利用公共数据库和ChIP-qPCR试验研究PPARγ途径在调节FABP1转录中的作用。
淋巴结转移后脂质代谢途径受到抑制,淋巴结中脂质分解代谢产物减少。单细胞数据也支持这些发现。生理浓度的AA可增加胃癌细胞的铁死亡敏感性、脂质过氧化和线粒体损伤。FABP1在淋巴结中显著下调,其介导了AA的摄取、线粒体破坏和脂质过氧化。进一步分析显示,FABP1转录调节因子PPARγ在淋巴结转移后显著下调。此外,我们的研究结果表明AA降低了PPARγ蛋白的稳定性。
淋巴结微环境中高浓度的AA可增加胃癌细胞对铁死亡的敏感性。机制上,AA抑制PPARγ途径以下调FABP1表达,从而抑制AA摄取并防止胃癌细胞发生铁死亡。